285 related articles for article (PubMed ID: 32530781)
1. Clinical evaluation of polyabsorbent TLC-NOSF dressings on chronic wounds: a prospective, observational, multicentre study of 1140 patients.
Dissemond J; Lützkendorf S; Dietlein M; Neßeler I; Becker E; Möller U; Thomassin L; Bohbot S; Münter KC
J Wound Care; 2020 Jun; 29(6):350-361. PubMed ID: 32530781
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of UrgoStart Plus dressings in real-life conditions: results of a prospective multicentre study on 961 patients.
Augustin M; Keuthage W; Lobmann R; Lützkendorf S; Groth H; Möller U; Thomassin L; Bohbot S; Dissemond J; Blome C
J Wound Care; 2021 Dec; 30(12):966-978. PubMed ID: 34881999
[TBL] [Abstract][Full Text] [Related]
3. The reality of routine practice: a pooled data analysis on chronic wounds treated with TLC-NOSF wound dressings.
Münter KC; Meaume S; Augustin M; Senet P; Kérihuel JC
J Wound Care; 2017 Feb; 26(Sup2):S4-S15. PubMed ID: 28182533
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of TLC-NOSF dressing with poly-absorbent fibres in exuding leg ulcers: two multicentric, single-arm, prospective, open-label clinical trials.
Sigal ML; Addala A; Maillard H; Chahim M; Sala F; Blaise S; Dalac S; Meaume S; Bohbot S; Tumba C; Tacca O
J Wound Care; 2019 Mar; 28(3):164-175. PubMed ID: 30840551
[TBL] [Abstract][Full Text] [Related]
5. Benefits of sucrose octasulfate (TLC-NOSF) dressings in the treatment of chronic wounds: a systematic review.
Nair H; Venkateshwaran N; Seetharaman S S; Deng W; Uthaipaisanwong A; Galea E
J Wound Care; 2021 Apr; 30(Sup4):S42-S52. PubMed ID: 33856929
[TBL] [Abstract][Full Text] [Related]
6. Use of a TLC-Ag dressing on 2270 patients with wounds at risk or with signs of local infection: an observational study.
Dissemond J; Dietlein M; Neßeler I; Funke L; Scheuermann O; Becker E; Thomassin L; Möller U; Bohbot S; Münter KC
J Wound Care; 2020 Mar; 29(3):162-173. PubMed ID: 32160091
[TBL] [Abstract][Full Text] [Related]
7. Optimal wound closure of diabetic foot ulcers with early initiation of TLC-NOSF treatment: post-hoc analysis of Explorer.
Lázaro-Martínez JL; Edmonds M; Rayman G; Apelqvist J; Van Acker K; Hartemann A; Martini J; Lobmann R; Bohbot S; Kerihuel JC; Piaggesi A
J Wound Care; 2019 Jun; 28(6):358-367. PubMed ID: 31166858
[TBL] [Abstract][Full Text] [Related]
8. TLC-Ag dressings: a prospective, multicentre study on 728 patients with wounds at risk of or with local infection.
Lützkendorf S; Grünerbel A; Dietlein M; Lüdemann C; Becker E; Möller U; Thomassin L; Bohbot S; Dissemond J
J Wound Care; 2022 May; 31(5):366-378. PubMed ID: 35579315
[TBL] [Abstract][Full Text] [Related]
9. Quality of life in patients with leg ulcers: results from CHALLENGE, a double-blind randomised controlled trial.
Meaume S; Dompmartin A; Lok C; Lazareth I; Sigal M; Truchetet F; Sauvadet A; Bohbot S;
J Wound Care; 2017 Jul; 26(7):368-379. PubMed ID: 28704156
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of TLC-NOSF dressings versus neutral dressings for the treatment of diabetic foot ulcers in France.
Maunoury F; Oury A; Fortin S; Thomassin L; Bohbot S;
PLoS One; 2021; 16(1):e0245652. PubMed ID: 33481840
[TBL] [Abstract][Full Text] [Related]
11. Management of diabetic foot ulcers with a TLC-NOSF wound dressing.
Richard JL; Martini J; Bonello Faraill MM; Bemba JM; Lepeut M; Truchetet F; Ehrler S; Schuldiner S; Sauvadet A; Bohbot S
J Wound Care; 2012 Mar; 21(3):142-7. PubMed ID: 22399083
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of MMP-inhibiting wound dressings in the treatment of chronic wounds: a systematic review.
Dissemond J; Augustin M; Dietlein M; Faust U; Keuthage W; Lobmann R; Münter KC; Strohal R; Stücker M; Traber J; Vanscheidt W; Läuchli S
J Wound Care; 2020 Feb; 29(2):102-118. PubMed ID: 32058850
[TBL] [Abstract][Full Text] [Related]
13. Association of autologous punch grafting, TLC-NOSF dressing and multitype compression therapy to rapidly achieve wound closure in hard-to-heal venous leg ulcers.
Conde-Montero E; Bohbot S; Grado Sanz R; Peral Vázquez A; Recarte-Marín L; Pérez-Jerónimo L; Galán Sánchez JL; de la Cueva Dobao P
J Med Vasc; 2020 Dec; 45(6):316-325. PubMed ID: 33248534
[TBL] [Abstract][Full Text] [Related]
14. Management of hard-to-heal leg ulcers with an acid-oxidising solution versus standard of care: the MACAN study.
Strohal R; Mittlböck M; Müller W; Hämmerle G
J Wound Care; 2021 Sep; 30(9):694-704. PubMed ID: 34554831
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of two fibrous wound dressings for the management of leg ulcers: results of a European randomised controlled trial (EARTH RCT).
Meaume S; Dissemond J; Addala A; Vanscheidt W; Stücker M; Goerge T; Perceau G; Chahim M; Wicks G; Perez J; Tacca O; Bohbot S
J Wound Care; 2014 Mar; 23(3):105-6,108-11, 114-6. PubMed ID: 24633056
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of TLC-sucrose octasulfate versus control dressings in the treatment of diabetic foot ulcers.
Lobmann R; Augustin M; Lawall H; Tigges W; Potempa C; Thiem H; Fietz C; Rychlik RP
J Wound Care; 2019 Dec; 28(12):808-816. PubMed ID: 31825772
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the nano-oligosaccharide factor lipido-colloid matrix in the local management of venous leg ulcers: results of a randomised, controlled trial.
Schmutz JL; Meaume S; Fays S; Ourabah Z; Guillot B; Thirion V; Collier M; Barrett S; Smith J; Bohbot S; Dompmartin A
Int Wound J; 2008 Jun; 5(2):172-82. PubMed ID: 18494623
[TBL] [Abstract][Full Text] [Related]
18. [Clinical cases about the therapeutic use of debriding dressing hidrodetersive polyacrylate fibers with TLC and foam dressings TLC-NOSF polyurethane in chronic wounds].
Blasco García C; Segovia Gómez T; Bermejo Martínez M; Cuesta Cuesta JJ; Alventosa Cortés AM
Rev Enferm; 2012 Oct; 35(10):9-14. PubMed ID: 23157065
[TBL] [Abstract][Full Text] [Related]
19. Multicomponent compression system use in patients with chronic venous insufficiency: a real-life prospective study.
Stücker M; Münter KC; Erfurt-Berge C; Lützkendorf S; Eder S; Möller U; Dissemond J
J Wound Care; 2021 May; 30(5):400-412. PubMed ID: 33979221
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of treating vascular leg ulcers with UrgoStart(®) and UrgoCell(®) Contact.
Augustin M; Herberger K; Kroeger K; Muenter KC; Goepel L; Rychlik R
Int Wound J; 2016 Feb; 13(1):82-7. PubMed ID: 24618370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
